IP Library Granted Patent US 8,138,169
Granted Patent B2
US 8,138,169 · App. 12/422,156 · Granted Mar 20, 2012

Combination therapy for bipolar disorder

Assignee: ComgenRx, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,138,169
App. No.
12/422,156
Granted
Mar 20, 2012
Kind
B2
Abstract

Treatment regimens for mood disorders that include administration of buprenorphine, alone or in combination with additional pharmacological agents are described. Specifically, treatment regimens that alleviate racing thoughts associated with bipolar disorder, and pharmaceutical compositions and kits for use therein are described. Dosing regimens, compositions, and kits including buprenorphine for treating mania associated with opioid withdrawal are also described.

Claims (16)

1. A method for treating a manic episode in a subject suffering from a bipolar disorder or a subtype thereof, comprising administering buprenorphine or a pharmaceutically acceptable salt thereof to the subject to treat the manic episode.

2. The method of claim 1 , wherein the bipolar disorder is bipolar I disorder.

3. The method of claim 1 , wherein the bipolar disorder is bipolar II disorder.

4. The method of claim 1 , wherein the bipolar disorder is mixed bipolar disorder.

5. The method of claim 4 , wherein the subject affected with the mixed bipolar disorder rapidly cycles between manic or hypomanic phases and depressive phases.

6. The method of claim 5 , wherein at least one episode of racing thoughts occurs during the depressive phase.

7. The method of claim 1 , wherein the bipolar disorder subtype is cyclothymia.

8. The method of claim 1 , wherein the bipolar disorder subtype is acute mania.

9. The method of claim 1 , further comprising administering an opioid antagonist.

10. The method of claim 9 , wherein the opioid antagonist comprises naloxone.

11. The method of claim 10 , wherein buprenorphine and naloxone are administered together in a unit dose.

12. The method of claim 11 , wherein about 2.0 mg of buprenorphine is administered in the unit dose.

13. The method of claim 11 , wherein about 8.0 mg of buprenorphine is administered in the unit dose.

14. The method of claim 1 , wherein about 2.0 mg of buprenorphine is administered to the subject.

15. The method of claim 1 , wherein about 8.0 mg of buprenorphine is administered to the subject.

16. The method of claim 1 , wherein a feature of the manic episode is that the subject experiences racing thoughts.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2010
From: ORONSKY, BRYAN T.; ORONSKY, NEIL C.
To: COMGENRX, INC.
Reel/Frame 023811/0670 →
Continuity (3)
Provisional Application 61050738 · May 6, 2008
Provisional Application 61044312 · Apr 11, 2008
Related Publication 20090311347A1 · Dec 17, 2009